{"entity":{"type":"insider","cik":"0001314595","url":"/insider/0001314595","json_url":"/insider/0001314595.json","name":"Podlesak Dennis","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":4,"first":"2006-06-02","last":"2025-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Podlesak Dennis","source":"filing","n_filings":4,"first_seen":"2006-06-02","last_seen":"2025-08-18"}],"transactions":[{"id":4101391,"accession":"0000950170-25-109815","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-25-109815","line_url":"/filing/0000950170-25-109815#line-6","is_derivative":false,"issuer_cik":"0001314595","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001314595","owner_cik":"0001314595","owner_name":"Podlesak Dennis","owner_display_name":"Podlesak Dennis","owner_url":"/insider/0001314595","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19200.0,"shares_display":"19,200","price_per_share":15.8422,"price_display":"15.84","price_state":"stated","total_value":304170.24,"total_display":"304,170.24","total_whole":"304,170","shares_owned_after":191763.0,"shares_owned_after_display":"191,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-18","scope":"insider"},{"id":4101384,"accession":"0000950170-25-109815","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-109815","line_url":"/filing/0000950170-25-109815#line-4","is_derivative":false,"issuer_cik":"0001314595","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001314595","owner_cik":"0001314595","owner_name":"Podlesak Dennis","owner_display_name":"Podlesak Dennis","owner_url":"/insider/0001314595","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19200.0,"shares_display":"19,200","price_per_share":15.5421,"price_display":"15.54","price_state":"stated","total_value":298408.32,"total_display":"298,408.32","total_whole":"298,408","shares_owned_after":191763.0,"shares_owned_after_display":"191,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-18","scope":"insider"},{"id":4101375,"accession":"0000950170-25-109815","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-109815","line_url":"/filing/0000950170-25-109815#line-2","is_derivative":false,"issuer_cik":"0001314595","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001314595","owner_cik":"0001314595","owner_name":"Podlesak Dennis","owner_display_name":"Podlesak Dennis","owner_url":"/insider/0001314595","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19200.0,"shares_display":"19,200","price_per_share":14.1938,"price_display":"14.19","price_state":"stated","total_value":272520.96,"total_display":"272,520.96","total_whole":"272,521","shares_owned_after":191763.0,"shares_owned_after_display":"191,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-14","filed_date":"2025-08-18","scope":"insider"},{"id":6863319,"accession":"0001562180-22-006705","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-22-006705","line_url":"/filing/0001562180-22-006705","is_derivative":false,"issuer_cik":"0001314595","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001314595","owner_cik":"0001314595","owner_name":"Podlesak Dennis","owner_display_name":"Podlesak Dennis","owner_url":"/insider/0001314595","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11975.0,"shares_display":"11,975","price_per_share":23.4327,"price_display":"23.43","price_state":"stated","total_value":280606.5825,"total_display":"280,606.58","total_whole":"280,607","shares_owned_after":75763.0,"shares_owned_after_display":"75,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-16","scope":"insider","n_lines":2},{"id":6863296,"accession":"0001562180-22-006705","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-006705","line_url":"/filing/0001562180-22-006705#line-2","is_derivative":false,"issuer_cik":"0001314595","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001314595","owner_cik":"0001314595","owner_name":"Podlesak Dennis","owner_display_name":"Podlesak Dennis","owner_url":"/insider/0001314595","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66840.0,"shares_display":"66,840","price_per_share":24.1978,"price_display":"24.20","price_state":"stated","total_value":1617380.952,"total_display":"1,617,380.95","total_whole":"1,617,381","shares_owned_after":75763.0,"shares_owned_after_display":"75,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-16","scope":"insider"},{"id":4993439,"accession":"0001562180-21-002912","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-002912","line_url":"/filing/0001562180-21-002912#line-1","is_derivative":false,"issuer_cik":"0001314595","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001314595","owner_cik":"0001314595","owner_name":"Podlesak Dennis","owner_display_name":"Podlesak Dennis","owner_url":"/insider/0001314595","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13967.0,"shares_display":"13,967","price_per_share":14.1102,"price_display":"14.11","price_state":"stated","total_value":197077.1634,"total_display":"197,077.16","total_whole":"197,077","shares_owned_after":43300.0,"shares_owned_after_display":"43,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-22","filed_date":"2021-04-22","scope":"insider"},{"id":3895876,"accession":"0001186120-06-000038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001186120-06-000038","line_url":"/filing/0001186120-06-000038","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314595","owner_name":"Podlesak Dennis","owner_display_name":"Podlesak Dennis","owner_url":"/insider/0001314595","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.902,"price_display":"9.90","price_state":"stated","total_value":9902.0,"total_display":"9,902.00","total_whole":"9,902","shares_owned_after":7235.0,"shares_owned_after_display":"7,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-31","filed_date":"2006-06-02","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001395937","name":"Syndax Pharmaceuticals Inc","url":"/issuer/0001395937","role":"Director","n_filings":3,"first_seen":"2021-04-22","last_seen":"2025-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0000858803","name":"AVANIR PHARMACEUTICALS","url":"/issuer/0000858803","role":"Director","n_filings":1,"first_seen":"2006-06-02","last_seen":"2006-06-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001314595","retrieved_at":"2026-08-25T00:06:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}